Th. Carlson et al., ACTIVATION OF ANTITHROMBIN-III ISOFORMS BY HEPARAN-SULFATE GLYCOSAMINOGLYCANS AND OTHER SULFATED POLYSACCHARIDES, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 474-480
Antithrombin III occurs naturally as two functionally distinct molecul
ar species that differ in glycosylation at Asn135. Whereas the predomi
nant, glycosylated isoform has high affinity for heparin, a quantitati
vely minor isoform lacking glycosylation at that site displays relativ
ely higher affinity for both heparins and heparinoids. We characterize
d the ability of various sulphated polysaccharides to potentiate the r
ates of thrombin inhibition by the isoforms. High-molecular-weight dex
tran sulphate was the most effective of those studied, increasing thro
mbin inhibition by the higher-affinity antithrombin III isoform up to
five-fold more efficiently than did heparin fractions with low-affinit
y for antithrombin III. In addition, dextran sulphate activated the hi
gher-affinity isoform as much as twelve times more effectively than it
did the lower-affinity isoform. Pentosan polysulphate was up to three
-fold, and some heparan sulphate fractions up to two-fold, more effect
ive with the higher, compared with the lower affinity, isoform. Hepara
n sulphate preparations less effectively increased the rate of thrombi
n inhibition than did the other low-affinity polysaccharides. Structur
e-function studies indicated positive correlations between activity an
d both polymer length and anionic group density of low-affinity sulpha
ted polysaccharides. The observed effects of the heparan sulphates on
this anticoagulant pathway, although of low potency, are consistent wi
th the hypotheses that these substances naturally regulate blood homeo
stasis in vascular tissues and that much of this function may be media
ted by the higher-affinity antithrombin III isoform.